See analyst estimates and all valuation multiples for Biopharmaceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $957B | 15.0x | 33.2x | |
| $554B | 5.9x | 15.5x | |
| $446B | 7.3x | 17.1x | |
| $372B | 4.8x | 12.1x | |
| $324B | 5.5x | 15.9x | |
| $299B | 4.6x | 10.0x | |
| $298B | 5.4x | 13.2x | |
| $273B | 5.7x | 11.7x | |
| $223B | 6.1x | 12.6x | |
| $191B | 3.1x | 7.7x | |
| $168B | 5.8x | 10.5x | |
| $150B | 3.1x | 8.0x | |
| $125B | 2.4x | 7.9x | |
| $122B | 2.8x | 8.2x | |
| $107B | 8.9x | 19.8x | |
| $85.9B | 1.6x | 7.7x | |
| $84.6B | 10.7x | 20.9x | |
| $77.1B | 2.7x | 9.9x | |
| $75.2B | 3.0x | 10.6x | |
| $66.6B | 4.1x | 12.2x | |
| $60.6B | 6.4x | 14.7x | |
| $54.6B | 11.7x | 39.1x | |
| $54.4B | 11.5x | 38.2x | |
| $54.2B | 5.7x | 19.5x | |
| $51.5B | 3.0x | 10.1x | |
| $42.7B | 6.8x | 24.0x | |
| $37.7B | 2.9x | 14.2x | |
| $37.2B | 3.4x | 15.7x | |
| $33.1B | 11.6x | 32.4x | |
| $29.1B | 2.3x | 9.6x | |
| $29.1B | 1.9x | 7.8x | |
| $29.1B | 13.8x | 35.8x | |
| $28.7B | 2.0x | 7.0x | |
| $27.4B | 2.8x | 9.0x | |
| $24.3B | 8.2x | 8.4x | |
| $22.5B | 2.2x | 6.3x | |
| $18.8B | 9.7x | 95.3x | |
| $18.4B | 58.3x | n/a | |
| $18.4B | 5.0x | 13.2x | |
| $17.5B | 2.0x | 8.2x | |
| $17.1B | 110.4x | 205.5x | |
| $15.3B | 10.9x | 33.0x | |
| $15.0B | 3.1x | 11.6x | |
| $14.2B | 4.6x | 11.9x | |
| $14.1B | 29.7x | -1397.4x | |
| $13.9B | 4.5x | 12.2x | |
| $13.5B | 48.0x | -290.8x | |
| $13.2B | 2.3x | 14.0x | |
| $13.1B | 3.3x | 13.1x | |
| $12.6B | 4.4x | 19.1x | |
| $12.6B | 2.1x | 14.2x | |
| $12.4B | 2.8x | 7.4x | |
| $12.4B | 4.0x | 10.0x | |
| $11.8B | 3.7x | 15.2x | |
| $11.8B | 0.3x | 5.0x | |
| $11.7B | n/a | n/a | |
| $11.6B | 5.2x | 14.1x | |
| $11.2B | 13.1x | 42.7x | |
| $11.1B | 4.0x | 15.5x | |
| $11.1B | 3.3x | 7.9x | |
| $10.9B | 2.9x | 11.7x | |
| $10.8B | 7.0x | 27.9x | |
| $10.4B | 1.7x | 5.4x | |
| $10.1B | 3.6x | 13.1x | |
| $9.4B | 1.5x | 11.9x | |
| $9.3B | 913.7x | -38.8x | |
| $9.3B | 6.9x | 10.6x | |
| $8.2B | n/a | n/a | |
| $8.0B | 26817.7x | -26.9x | |
| $8.0B | 19.5x | -3260.5x | |
| $8.0B | 4.2x | 20.3x | |
| $7.9B | 1.5x | 12.5x | |
| $7.9B | n/a | n/a | |
| $7.6B | 2.8x | 4.1x | |
| $7.5B | 2.0x | 9.9x | |
| $7.4B | 4.7x | 23.7x | |
| $7.3B | 92.5x | 16205.2x | |
| $7.1B | 3.0x | 9.0x | |
| $7.0B | 2.3x | 10.1x | |
| $6.6B | 2.2x | 9.7x | |
| $6.5B | 2.1x | 8.6x | |
| $6.4B | 8.4x | 30.7x | |
| $6.4B | 1.4x | 8.5x | |
| $6.2B | n/a | n/a | |
| $6.1B | n/a | n/a | |
| $6.1B | 3.4x | 23.0x | |
| $6.0B | 1.8x | 7.1x | |
| $6.0B | 16.6x | 24.7x | |
| $6.0B | 6.9x | 24.3x | |
| $5.8B | n/a | -21.5x | |
| $5.7B | 9.6x | 28.7x | |
| $5.5B | 3.6x | 40.8x | |
| $5.5B | 2.8x | 10.5x | |
| $5.4B | 1.9x | 5.2x | |
| $5.3B | n/a | n/a | |
| $5.1B | 1.9x | 11.2x | |
| $5.1B | 6.0x | 30.6x | |
| $5.0B | 10.3x | 31.1x | |
| $4.9B | 13.5x | -73.6x | |
| $4.7B | n/a | -28.6x | |
| $4.6B | 5.0x | 13.6x | |
| $4.5B | n/a | n/a | |
| $4.5B | n/a | -11.3x | |
| $4.3B | 8.3x | 21.8x | |
| $4.3B | 10.0x | 30.5x | |
| $4.3B | 5.0x | 18.7x | |
| $4.3B | n/a | n/a | |
| $4.2B | 8.2x | 17.8x | |
| $4.1B | 2.9x | 10.7x | |
| $4.1B | 2.8x | 10.9x | |
| $4.0B | 3.8x | 17.4x | |
| $3.8B | 2.2x | 10.9x | |
| $3.7B | n/a | -33.4x | |
| $3.7B | 5.5x | 15.9x | |
| $3.7B | n/a | n/a | |
| $3.5B | 5.2x | 14.1x | |
| $3.5B | 5.0x | 14.5x | |
| $3.4B | n/a | n/a | |
| $3.4B | 28.9x | -529.0x | |
| $3.3B | 2.4x | 8.8x | |
| $3.3B | 2.5x | 11.9x | |
| $3.2B | 8.9x | -1665.7x | |
| $3.1B | 15.9x | 27.4x | |
| $3.0B | 1.5x | 9.7x | |
| $2.9B | 106.5x | -13.8x | |
| $2.9B | 4.6x | 11.4x | |
| $2.8B | 6.3x | -44.2x | |
| $2.8B | 4.8x | 21.1x | |
| $2.7B | 3.9x | 21.4x | |
| $2.7B | n/a | n/a | |
| $2.7B | 107.6x | -11.0x | |
| $2.7B | 3.9x | 24.8x | |
| $2.6B | 5.3x | 296.0x | |
| $2.6B | 4.2x | 13.7x | |
| $2.6B | 6.4x | 19.0x | |
| $2.6B | 34.5x | -19.2x | |
| $2.5B | n/a | n/a | |
| $2.5B | n/a | n/a | |
| $2.5B | 8.7x | 107.5x | |
| $2.5B | n/a | -17.2x | |
| $2.4B | 2.9x | 14.5x | |
| $2.4B | 57.9x | -12.1x | |
| $2.4B | n/a | -11.4x | |
| $2.4B | 12.9x | 38.0x | |
| $2.4B | n/a | n/a | |
| $2.3B | 6.1x | 17.6x | |
| $2.3B | 2.6x | 10.0x | |
| $2.2B | 7.1x | 18.6x | |
| $2.2B | 3.4x | 13.5x | |
| $2.1B | 13.7x | 30.3x | |
| $2.1B | n/a | -8.8x | |
| $2.0B | 7.3x | 58.5x | |
| $2.0B | n/a | -11.9x | |
| $2.0B | 13.4x | 33.4x | |
| $2.0B | 2.6x | 4.4x | |
| $2.0B | 8.0x | -5.4x | |
| $2.0B | 7.2x | 27.9x | |
| $1.9B | n/a | n/a | |
| $1.9B | n/a | -11.0x | |
| $1.8B | 2.7x | 12.7x | |
| $1.7B | n/a | n/a | |
| $1.7B | 4.1x | 14.0x | |
| $1.7B | n/a | n/a | |
| $1.7B | 6.0x | 11.3x | |
| $1.7B | 4.2x | -395.4x | |
| $1.7B | 15.3x | 296.0x | |
| $1.6B | 6.6x | 281.5x | |
| $1.6B | n/a | n/a | |
| $1.6B | 0.7x | 4.2x | |
| $1.6B | 29.2x | n/a | |
| $1.6B | 2.2x | 6.0x | |
| $1.6B | n/a | -11.1x | |
| $1.5B | 12.6x | -29.6x | |
| $1.5B | n/a | n/a | |
| $1.5B | 10.6x | 26.2x | |
| $1.5B | 6.3x | 35.4x | |
| $1.5B | n/a | -16.8x | |
| $1.5B | n/a | n/a | |
| $1.5B | 652.5x | n/a | |
| $1.5B | 33.5x | 212.9x | |
| $1.5B | 23.2x | -13.6x | |
| $1.4B | n/a | -14.7x | |
| $1.4B | 7.5x | 128.9x | |
| $1.4B | 4.2x | 57.5x | |
| $1.4B | 39.0x | n/a | |
| $1.4B | 4.9x | 26.4x | |
| $1.4B | 4.8x | 9.4x | |
| $1.4B | 11.1x | 42.1x | |
| $1.3B | 8.0x | -5.1x | |
| $1.3B | 487.0x | -8.5x | |
| $1.3B | n/a | -6.8x | |
| $1.3B | n/a | -9.8x | |
| $1.2B | 3.4x | 40.2x | |
| $1.2B | 7.2x | -8.9x | |
| $1.2B | 1.2x | 5.1x | |
| $1.2B | 3.0x | 5.2x | |
| $1.2B | 1179.8x | -11.9x | |
| $1.2B | 4.0x | 7.9x | |
| $1.2B | 9.9x | 31.8x | |
| $1.2B | 0.6x | 4.4x | |
| $1.2B | n/a | n/a | |
| $1.2B | n/a | -5.8x | |
| $1.2B | 2.0x | -49.8x | |
| $1.1B | 2.4x | 13.2x | |
| $1.1B | n/a | n/a | |
| $1.1B | 2.8x | 12.2x | |
| $1.1B | n/a | n/a | |
| $1.0B | 110.1x | -8.8x | |
| $1.0B | 121991.3x | -8.9x | |
| $993M | 1.2x | 4.9x | |
| $989M | 1.6x | 8.0x | |
| $978M | 1.6x | -7.2x | |
| $956M | 2.4x | 36.3x | |
| $956M | 1143.1x | -84.7x | |
| $951M | n/a | n/a | |
| $916M | 8.1x | -7.8x | |
| $913M | 2.2x | 2.6x | |
| $866M | 1.9x | 9.1x | |
| $838M | n/a | -5.8x | |
| $825M | 60.5x | n/a | |
| $802M | 2.8x | 12.2x | |
| $780M | 26.7x | -3.8x | |
| $779M | n/a | -6.6x | |
| $776M | 19.9x | -12.4x | |
| $766M | n/a | n/a | |
| $763M | n/a | n/a | |
| $759M | 59.5x | -2.4x | |
| $756M | n/a | -3.4x | |
| $733M | 530.8x | -132.7x | |
| $723M | n/a | n/a | |
| $659M | n/a | n/a | |
| $629M | 4.2x | -5.2x | |
| $626M | n/a | -4.2x | |
| $604M | n/a | -3.9x | |
| $603M | 85.2x | -3.8x | |
| $603M | n/a | n/a | |
| $566M | 36.5x | -11.4x | |
| $556M | n/a | n/a | |
| $556M | 3.2x | 19.9x | |
| $551M | 14.8x | 57.0x | |
| $550M | n/a | n/a | |
| $542M | 41.7x | -6.9x | |
| $542M | 4.2x | -3.3x | |
| $539M | n/a | n/a | |
| $534M | n/a | n/a | |
| $530M | n/a | n/a | |
| $523M | 20398.2x | n/a | |
| $502M | 7.9x | -22.6x | |
| $499M | 2.5x | -4.7x | |
| $496M | n/a | n/a | |
| $493M | 69.8x | -5.5x | |
| $490M | n/a | n/a | |
| $446M | 19.6x | -8.7x | |
| $443M | 32.6x | n/a | |
| $441M | 2.3x | 9.7x | |
| $428M | n/a | n/a | |
| $420M | 1.3x | 9.3x | |
| $418M | 2.3x | 9.5x | |
| $407M | 8.6x | -6.6x | |
| $398M | 6.2x | 23.9x | |
| $395M | 86.9x | -12.7x | |
| $395M | n/a | n/a | |
| $380M | 20.0x | -4.8x | |
| $376M | 1.1x | 4.2x | |
| $370M | 1.3x | 10.5x | |
| $368M | n/a | n/a | |
| $364M | 35.8x | -8.3x | |
| $361M | 2.8x | 32.2x | |
| $357M | n/a | n/a | |
| $334M | n/a | n/a | |
| $331M | 5.9x | n/a | |
| $327M | n/a | n/a | |
| $320M | 4.6x | 34.5x | |
| $316M | n/a | n/a | |
| $312M | 0.8x | 9.2x | |
| $302M | 3.1x | 10.4x | |
| $298M | 48.7x | -1.3x | |
| $285M | 1268.4x | -6.3x | |
| $280M | 4.2x | 9.1x | |
| $262M | n/a | n/a | |
| $257M | n/a | n/a | |
| $253M | 5.5x | 44.6x | |
| $253M | 50.5x | -3.6x | |
| $249M | n/a | n/a | |
| $248M | 56580.7x | -2.8x | |
| $247M | n/a | -36.4x | |
| $242M | 1.0x | n/a | |
| $240M | 2.7x | -11.3x | |
| $237M | 12.3x | -5.6x | |
| $233M | 1.7x | 15.5x | |
| $231M | 63.6x | -4.2x | |
| $226M | n/a | n/a | |
| $222M | n/a | n/a | |
| $215M | 5.4x | -27.8x | |
| $214M | 4.7x | 23.3x | |
| $210M | 6.7x | -2.9x | |
| $200M | n/a | -3.3x | |
| $200M | 2.5x | 96.2x | |
| $188M | 2.9x | n/a | |
| $186M | 25.9x | -5.8x | |
| $185M | n/a | n/a | |
| $181M | 21.3x | -18.8x | |
| $180M | n/a | n/a | |
| $177M | 16.3x | n/a | |
| $171M | n/a | -2.7x | |
| $163M | 9.8x | -4.0x | |
| $163M | 2.9x | 749.0x | |
| $155M | 7.3x | 71.8x | |
| $152M | 4.5x | -0.7x | |
| $151M | n/a | n/a | |
| $149M | 27.9x | -12.8x | |
| $145M | 4.7x | 7.1x | |
| $144M | 2.3x | n/a | |
| $142M | 5.5x | -4.0x | |
| $138M | n/a | -1.0x | |
| $137M | 34.2x | -9.8x | |
| $135M | n/a | n/a | |
| $132M | n/a | -10.2x | |
| $127M | n/a | n/a | |
| $127M | 7.5x | -2.2x | |
| $122M | 13.5x | -5.4x | |
| $117M | 22.0x | -12.4x | |
| $117M | n/a | -31.9x | |
| $116M | n/a | n/a | |
| $114M | n/a | n/a | |
| $109M | 9.1x | 163.8x | |
| $109M | 1.5x | 9.2x | |
| $101M | n/a | n/a | |
| $97.3M | 68.0x | -18.1x | |
| $97.3M | 7.6x | -3.5x | |
| $90.2M | n/a | n/a | |
| $86.7M | n/a | n/a | |
| $81.7M | 1.1x | -0.3x | |
| $77.2M | 0.9x | 5.5x | |
| $73.1M | n/a | n/a | |
| $71.5M | n/a | n/a | |
| $69.8M | n/a | n/a | |
| $68.9M | 6.9x | 15.0x | |
| $68.0M | n/a | n/a | |
| $65.8M | n/a | n/a | |
| $65.3M | 0.7x | -1.1x | |
| $63.7M | n/a | n/a | |
| $60.1M | n/a | n/a | |
| $59.8M | n/a | -9.9x | |
| $58.4M | 9.3x | -1.1x | |
| $56.8M | n/a | n/a | |
| $55.1M | n/a | n/a | |
| $53.2M | n/a | n/a | |
| $52.2M | n/a | n/a | |
| $51.2M | 58.9x | -4.9x | |
| $50.7M | n/a | n/a | |
| $50.5M | 5.0x | 2.2x | |
| $48.3M | n/a | n/a | |
| $48.2M | 33.5x | -60.6x | |
| $45.3M | n/a | n/a | |
| $42.2M | n/a | -3.3x | |
| $39.5M | 10.0x | -1.3x | |
| $38.6M | 4.9x | -1.9x | |
| $37.6M | n/a | n/a | |
| $37.4M | n/a | -5.7x | |
| $37.2M | n/a | n/a | |
| $36.7M | 56.2x | -3.6x | |
| $36.6M | 10.1x | -9.1x | |
| $36.5M | 4.9x | n/a | |
| $33.7M | n/a | n/a | |
| $33.0M | n/a | n/a | |
| $32.1M | n/a | n/a | |
| $30.0M | 0.1x | -0.7x | |
| $29.5M | 10.8x | -5.5x | |
| $29.5M | 8.3x | -4.9x | |
| $28.3M | 7.3x | n/a | |
| $26.9M | n/a | n/a | |
| $26.8M | n/a | n/a | |
| $26.8M | n/a | -15.0x | |
| $26.3M | n/a | n/a | |
| $25.6M | n/a | n/a | |
| $25.6M | 125.9x | -5.6x | |
| $23.5M | 10.7x | -0.3x | |
| $23.3M | n/a | n/a | |
| $22.4M | 16.6x | -8.0x | |
| $20.6M | n/a | n/a | |
| $20.4M | n/a | n/a | |
| $20.2M | n/a | n/a | |
| $19.9M | n/a | n/a | |
| $19.5M | 2.8x | 7.8x | |
| $19.3M | n/a | n/a | |
| $18.8M | 18.8x | -0.7x | |
| $17.8M | n/a | n/a | |
| $17.3M | n/a | n/a | |
| $17.2M | n/a | n/a | |
| $16.9M | 38.7x | -2.6x | |
| $16.7M | 1.1x | -10.0x | |
| $16.4M | n/a | n/a | |
| $16.2M | 7.4x | 1.6x | |
| $16.1M | n/a | -3.6x | |
| $15.8M | n/a | -3.8x | |
| $15.0M | n/a | n/a | |
| $14.6M | 2.6x | -5.6x | |
| $14.5M | n/a | n/a | |
| $13.8M | n/a | n/a | |
| $13.5M | n/a | n/a | |
| $13.5M | n/a | n/a | |
| $13.3M | n/a | n/a | |
| $13.2M | n/a | n/a | |
| $12.3M | n/a | n/a | |
| $12.0M | 8.6x | -0.7x | |
| $11.4M | 149.6x | -5.0x | |
| $11.4M | 7.6x | -34.0x | |
| $10.6M | n/a | n/a | |
| $10.4M | n/a | -2.1x | |
| $10.2M | n/a | n/a | |
| $10.0M | n/a | n/a | |
| $10.0M | 5.7x | -0.8x | |
| $9.9M | n/a | -2.5x | |
| $9.8M | n/a | n/a | |
| $9.6M | 1.6x | -1.0x | |
| $9.3M | 9.1x | -37.0x | |
| $9.1M | n/a | n/a | |
| $8.8M | n/a | n/a | |
| $8.6M | n/a | n/a | |
| $8.1M | n/a | n/a | |
| $7.8M | n/a | n/a | |
| $7.5M | n/a | n/a | |
| $7.4M | n/a | n/a | |
| $7.1M | 65.5x | -2.3x | |
| $7.0M | 2.0x | -2.7x | |
| $7.0M | n/a | -2.3x | |
| $6.9M | n/a | -2.0x | |
| $6.9M | n/a | n/a | |
| $6.6M | n/a | n/a | |
| $6.5M | n/a | n/a | |
| $5.8M | n/a | n/a | |
| $5.3M | 8.2x | -4.5x | |
| $5.0M | 5.0x | n/a | |
| $4.8M | 3.6x | -1.3x | |
| $4.0M | n/a | n/a | |
| $3.9M | n/a | n/a | |
| $3.0M | n/a | n/a | |
| $2.9M | n/a | n/a | |
| $2.9M | n/a | n/a | |
| $2.8M | 2.2x | -0.4x | |
| $2.8M | n/a | n/a | |
| $2.7M | n/a | n/a | |
| $2.6M | n/a | n/a | |
| $2.4M | n/a | n/a | |
| $2.3M | n/a | n/a | |
| $2.2M | n/a | n/a | |
| $2.1M | n/a | n/a | |
| $1.9M | n/a | n/a | |
| $1.8M | n/a | n/a | |
| $1.8M | n/a | n/a | |
| $1.4M | n/a | -1.9x | |
| $1.3M | n/a | n/a | |
| $0.9M | n/a | n/a | |
| $0.6M | n/a | -1.1x | |
| $0.1M | n/a | n/a | |
| -$0.2M | n/a | n/a | |
| -$0.5M | n/a | n/a | |
| -$0.8M | n/a | n/a | |
| -$0.9M | n/a | 0.2x | |
| -$1.0M | n/a | n/a | |
| -$1.4M | -0.9x | n/a | |
| -$3.6M | n/a | n/a | |
| -$6.7M | n/a | n/a | |
| -$18.2M | n/a | n/a | |
| -$32.9M | n/a | n/a | |
| -$51.3M | -3.0x | 0.3x | |
| -$103M | n/a | 0.6x | |
| -$1.3B | -4.2x | 4.3x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Biopharmaceuticals